# KKR & CO. INC. (KKR) · Edgar & Edgarette company card

> Kkr & Co. Inc. (KKR) saw revenue fall 11.0% in FY2025 to $19.5 billion, equity 7.5% of assets, and dividend per share up 7 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1404912 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/KKR) · [JSON](https://www.pops4.com/boards/company/KKR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $19.5B |
| Revenue growth, 1 year | -11.0% |
| Revenue growth per year | 4.7% |
| Operating margin | — |
| Net margin | 31.6% |
| Operating cash flow | $478M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $17.2B |
| Long-term debt | — |
| Total assets | $410.1B |
| Total equity | $30.9B |
| Equity ÷ assets | 7.5% |
| Return on equity | 19.9% |
| Dividend per share | $0.73 |
| Dividend years rising | 7 |

## Readings, computed from those figures

- Piotroski F: 4 of 9 (4 of 6 tested)
- Health Harbor boat: Sound ship · one warning sign · revenue is hard to predict: its 80% range is ±67%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $19.5B (FY2025). Experience: revenue down 11.0% on the year, up 4.7% a year over 4 years. Soundness: equity 7.5% of assets, return on equity 19.9%, payout 10.6% of profit, dividend per share up 7 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $9.7B and $49.2B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $4.7B to $94.5B. A statistical range, not company guidance. Against peers (22 filers, $50M+ revenue, investment advice): growth -11.0% against 7.5%.

Range logged 2026-09-26, receipt 451d61452167ec6c, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-10-26 ([filing](https://www.sec.gov/Archives/edgar/data/1404912/000114036126040706/0001140361-26-040706-index.htm))

## Recent filings

- 10-Q · filed 2026-11-09 · [filing](https://www.sec.gov/Archives/edgar/data/1404912/000140491226000034/0001404912-26-000034-index.htm)
- 8-K · filed 2026-11-09 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1404912/000140491226000030/0001404912-26-000030-index.htm)
- 8-K · filed 2026-11-04 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1404912/000114036126041894/0001140361-26-041894-index.htm)
- 8-K · filed 2026-10-26 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1404912/000114036126040706/0001140361-26-040706-index.htm)
- 8-K · filed 2026-08-31 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1404912/000114036126034930/0001140361-26-034930-index.htm)
- 8-K · filed 2026-08-27 · 7.01 Regulation FD Disclosure; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1404912/000114036126034520/0001140361-26-034520-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001404912.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1404912

## Cite

POPS4, Edgar & Edgarette: KKR & CO. INC. (KKR) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/KKR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.